8 research outputs found

    Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia

    Get PDF
    Eltrombopag is an oral thrombopoietin-receptor agonist. This study evaluated the efficacy of eltrombopag for increasing platelet counts and reducing the need for platelet transfusions in patients with thrombocytopenia and chronic liver disease who are undergoing an elective invasive procedure

    Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

    No full text

    Population biology of human aging

    No full text
    corecore